阅读说明：本技术 用于治疗rna病毒感染的苯基/吡啶基-n-苯基/吡啶基衍生物 (phenyl/pyridyl-N-phenyl/pyridyl derivatives for the treatment of RNA viral infections ) 是由 D·谢雷 J·塔齐 F·马于托-贝茨尔 R·纳日曼 J·桑托 C·阿波利特 于 2019-07-09 设计创作，主要内容包括：本发明涉及式(Ic)的化合物或其药学上可接受的盐中的任一种其中X～2代表-CO-NR-k-基团,其中R-k代表氢原子或甲基、-NH-CO-NH-基团、-OCH-2-基团、-CH(OH)-基团、-NH-CO-基团、-O-基团、-O-(CH-2)-s-O-、-CO-基团、-SO-2-基团、包含1、2、3或4个杂原子的二价5-元杂芳族环、-NH-SO-2-或-SO-2-NH-基团；Y～2代表氢原子、卤素原子、羟基、(C-1-C-4)烷氧基、基团、基团、任选地被(C-1-C-4)烷基基团取代的吗啉基基团、哌嗪基基团、哌啶基基团或-CR～1R～2R～3基团。本发明进一步涉及新化合物,涉及含有它们的药物组合物,并涉及用于制备它们的合成方法。(The present invention relates to any one of the compounds of formula (Ic) or a pharmaceutically acceptable salt thereof Wherein X 2 represents-CO-NR k A group in which R k Represents a hydrogen atom or a methyl group, -NH-CO-NH-group, -OCH 2 -a group, -CH (OH) -a group, -NH-CO-a group, -O- (CH) 2 ) s -O-, -CO-groups, -SO 2 -a group, a divalent 5-membered heteroaromatic ring comprising 1,2,3 or 4 heteroatoms, -NH-SO 2 -or-SO 2 -an NH-group; y is 2 Represents a hydrogen atom, a halogen atom, a hydroxyl group, or (C) 1 ‑C 4 ) Alkoxy radical, A group, Radical, optionally substituted (C) 1 ‑C 4 ) Morpholinyl radicals, piperazinyl radicals, piperidinyl radicals or-CR substituted by alkyl radicals 1 R 2 R 3 A group. The invention further relates to novel compounds, to pharmaceutical compositions containing them and to synthetic processes for preparing them.)